Correlation Between C4 Therapeutics and Decibel Therapeutics
Can any of the company-specific risk be diversified away by investing in both C4 Therapeutics and Decibel Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining C4 Therapeutics and Decibel Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between C4 Therapeutics and Decibel Therapeutics, you can compare the effects of market volatilities on C4 Therapeutics and Decibel Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in C4 Therapeutics with a short position of Decibel Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of C4 Therapeutics and Decibel Therapeutics.
Diversification Opportunities for C4 Therapeutics and Decibel Therapeutics
0.22 | Correlation Coefficient |
Modest diversification
The 3 months correlation between CCCC and Decibel is 0.22. Overlapping area represents the amount of risk that can be diversified away by holding C4 Therapeutics and Decibel Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Decibel Therapeutics and C4 Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on C4 Therapeutics are associated (or correlated) with Decibel Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Decibel Therapeutics has no effect on the direction of C4 Therapeutics i.e., C4 Therapeutics and Decibel Therapeutics go up and down completely randomly.
Pair Corralation between C4 Therapeutics and Decibel Therapeutics
Given the investment horizon of 90 days C4 Therapeutics is expected to generate 1.45 times less return on investment than Decibel Therapeutics. In addition to that, C4 Therapeutics is 1.56 times more volatile than Decibel Therapeutics. It trades about 0.02 of its total potential returns per unit of risk. Decibel Therapeutics is currently generating about 0.05 per unit of volatility. If you would invest 254.00 in Decibel Therapeutics on August 28, 2024 and sell it today you would earn a total of 54.00 from holding Decibel Therapeutics or generate 21.26% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 28.78% |
| Values | Daily Returns |
C4 Therapeutics vs. Decibel Therapeutics
Performance |
| Timeline |
| C4 Therapeutics |
| Decibel Therapeutics |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
C4 Therapeutics and Decibel Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with C4 Therapeutics and Decibel Therapeutics
The main advantage of trading using opposite C4 Therapeutics and Decibel Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if C4 Therapeutics position performs unexpectedly, Decibel Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Decibel Therapeutics will offset losses from the drop in Decibel Therapeutics' long position.| C4 Therapeutics vs. Shattuck Labs | C4 Therapeutics vs. Eliem Therapeutics | C4 Therapeutics vs. Prelude Therapeutics | C4 Therapeutics vs. Monte Rosa Therapeutics |
| Decibel Therapeutics vs. Werewolf Therapeutics | Decibel Therapeutics vs. Edgewise Therapeutics | Decibel Therapeutics vs. Celcuity LLC | Decibel Therapeutics vs. C4 Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.
Other Complementary Tools
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios |